Related Experiment Video
Updated: May 20, 2025

11:02
Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
Published on: November 29, 2024
420
Optimizing metabolic health with digital twins.
Chengxun Su1,2, Peter Wang1,2,3, Nigel Foo1,2,3
1The Institute for Digital Medicine (WisDM), National University of Singapore, Singapore, Singapore.
Npj Aging
|March 25, 2025
Summary
Digital twins can optimize metabolic health by modeling individual metabolic flexibility. This approach gamifies health improvements and predicts outcomes, aiding early detection of metabolic decline.
Area of Science:
- Metabolic health and digital twin technology.
Background:
- Subclinical metabolic decline is characterized by impaired metabolic flexibility.
- Metabolic flexibility is the body's ability to switch fuel sources (glucose and fat) based on energy needs.
Purpose of the Study:
- To propose digital twins for optimizing metabolic health.
- To model individual metabolic flexibility profiles.
- To gamify health optimization and predict long-term outcomes.
Main Methods:
- Developing digital twins to model metabolic flexibility.
- Exploring technological and socioeconomic aspects of the approach.
- Utilizing gamification for behavior change.
Main Results:
- Digital twins offer a novel approach to metabolic health optimization.
- The technology can predict long-term health outcomes.
- Gamification can drive behavior change for metabolic health.
Conclusions:
- Digital twins hold promise for personalized metabolic health management.
- This approach can reduce the burden of metabolic disorders.
- Early detection of metabolic decline is facilitated by digital twin modeling.
Related Concept Videos
What is Metabolism?
112.7K
Overview
112.7K
Diabetes: Management and Pharmacotherapy
216
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
216

